We have launched a campaign to reclassify schizophrenia as a neurological brain illness and inform the entire community this illness deserves treatment, not punishment. This campaign has included letters to the CDC and World Health Organization with support by the non-federal members of the ISMICC.
Since 1985, thousands of people have been supported by more than 150 Schizophrenia Alliance support groups that meet throughout the United States, Australia, Brazil, Canada, Mexico, France, Russia, Germany, India, Hungary, Singapore, Uruguay, Japan, Kenya, Iran, and Venezuela.
Virtual SA groups and Families for Care Support (FFC) groups provide individuals with the opportunity to connect with others affected by psychosis spectrum disorders, engage with treatment providers, find support, become educated, and increase their understanding. Both groups have increased in participation from just two participants to hundreds of regular attendees. To meet this demand, groups have gone from one meeting per week up to twelve times each week.
SCZ Health StorylinesTM App
In October 2015, we launched the SCZ Health StorylinesTM app for diagnosed individuals and caregivers. Created in partnership with Self Care Catalysts, this app was designed based on feedback from diagnosed individuals and caregivers. Today, there are approximately 1,000 downloads of the app.
The Keshavan Lab at Beth Israel Deaconess Medical Center and Harvard Medical School also collaborated with us in our unified mission to better understand schizophrenia, offer the best care possible to diagnosed individuals, and provide support for families.
Using the Health StorylinesTM app, the Keshavan Lab is learning more about the experiences of those living with schizophrenia outside of typical clinic settings through real-time information about symptoms and community interactions. We hope to learn much more from this anonymized information collected by the Health StorylinesTM app.
In collaboration with theBloc, we launched Hearing Voices of Support (HVoS) in October 2016. HVoS is an initiative to help ensure people affected by schizophrenia-related brain illnesses are heard and, in return, hear voices of support from the wider community. On October 30, 2016, the first billboard highlighting schizophrenia launched in Times Square. On December 8, 2016, more than 40 volunteers formed a flash mob and sang “Brave” in the middle of Times Square to highlight the need for positive support for people affected by psychosis spectrum disorders.
The first HVoS Experiential Event was held in New York City during Schizophrenia Awareness Week, the third week of May. HVoS garnered great attention as a “first” in a powerful positive effort to educate and eliminate stigma and discrimination about psychosis spectrum disorders. Our organization has since received major grants to help with the production of the experiential event and will install the next event in Washington, D.C. in conjunction with a scientific briefing for legislators.
The HVoS Perception Changing Art Installation included exit interviews and written surveys that indicated that nearly 90% of the participants left better understanding schizophrenia and felt the need to help people who experience psychosis spectrum disorders.
Television, cable, radio, and other media interviews as well as videos with individuals affected by schizophrenia spectrum brain illnesses have helped communities understand that schizophrenia is a neural-circuitry brain illness and everyone deserves treatment, not punishment. Understanding, education, and compassion built through this outreach will produce a paradigm shift and bring treatment to our family members, colleagues, and neighbors instead of inhumane incarceration and homelessness.
Recently, S&PAA coordinated an hour-long interview on CNN en Espanol with Ismael Cala on The Cala Show. The interview included our founder, the Uruguay SA leader, and a psychiatrist. This program brought an opportunity for understanding to more than two million watchers.
Schizophrenia & Psychosis Action Alliance engages with people on various social networking platforms and also releases a bimonthly email newsletter and blog to share up-to-date information.
We have developed partnerships with many stakeholders to help advance our initiative.
Our national conferences have been held annually since 2012 in Houston, Texas; Detroit, Michigan; Bethesda, Maryland; Rochester, New York; New York City; and virtually from Hollywood, Florida during COVID-19.
Conferences provide friends, families, and professionals with knowledge to aid individuals in recovery. They also focus on the challenges faced by professionals, the criminal justice system, and policymakers.
Speakers have included:
We were proud and honored to nominate Dr. Tamara Navarro in 2012 and Dr. Fredrick Frese in 2013 for the Lilly Reintegration Award for Mentorship and Advocacy. The National Council for Community Behavioral Healthcare recognized both nominees with one of their most prestigious awards in behavioral healthcare.
S&PAA is proud to honor outstanding individuals working courageously in the face of devastating obstacles to educate professionals, the public, and diagnosed individuals, eliminate stigma and discrimination, advocate for access to treatment, provide dignity for people living with severe psychiatric brain disorders, and maintain their own personal recovery journey. Awards include:
Joanne Verbanic Award (Founders Award)
This award was initiated by Joanne Verbanic, founder of Schizophrenia Alliance, to recognize those offering immense dedication, inspiration, encouragement, and an unwavering belief in people living with schizophrenia and related disorders. Recipients also support the growth of the Schizophrenia Alliance self-help and peer support network.
Past recipients include: Nora Bylerian, Mike Carr, and Sue Dutch
This award recognizes exemplary individuals who are brain health advocates and work to educate the public about severe neuropsychiatric illnesses all while actively participating in their own personal recovery journey.
Past recipients include: Patrick J. Kennedy, Brandon Staglin, Joanne Verbanic Margery Wakefield, Michelle Hammer, Calen Pick, Megan MacNichol, and Bethany Yeiser
This award recognizes journalists who take significant interest in presenting brain health issues and report brain illness in ways that break myths and shatter stigma with factual information.
Past recipients include: theBloc, Pete Earley, Brianna Ehley, and Richard Gere
This award recognizes providers (physicians, nurses, NPs, social workers, healthcare workers, etc.) who go above and beyond routine requirements to enhance patient care, improve understanding of neuropsychiatric illness, employ innovative and cutting edge interventions, and remain open to patient input for improving services.
Past recipients include: Dr. Robert Laitman, Dr. Robert Moran, and Dr. Michael Mufson
This award recognizes individuals who have utilized legislative initiatives to improve the quality of life and care for individuals affected by schizophrenia and related brain illnesses. Recipients may include individuals in mental health recovery, state or federal legislators, or family members who have proposed or responded to local or national legislation that impacts treatment or the rights of people with a severe neuropsychiatric diagnosis
Past recipients include: Congressman Dr. Tim Murphy, Congresswoman Eddie Bernice Johnson, and Florida State Senator Gayle Harrell
This award recognizes researchers who have designed and implemented studies to enhance the diagnoses or care of those affected by neuropsychiatric illness. Recipients are dedicated to pushing the boundaries of science and including the voices of patients and families through their work.
Past recipients include: Dr. Robert Heinssen, Dr. Deborah Levy, and Dr. Robert Freedman
Information on this website is not intended to be used for medical diagnosis or treatment.
We are a 501 (c)(3) tax-exempt non-profit organization (Tax ID 33-1213657)
We need your support for the Cost of Mental Illness Act. This bill would provide the accurate and comprehensive data needed to create policies that ease the burden of schizophrenia and other serious mental illness while improving lives. Show your support and encourage your United States Representative to vote for this bill.